The Role of intraABDOminal Pressure and Point Of Care UltraSound to Guide Decongestive Therapy in Heart Failure

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 168 participants.

Also called NCT07008365

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 168 participants (planned count) (from the registry)
Sponsor
Instituto de Investigación Sanitaria Aragón (from the registry)
Registry
  • NCT NCT07008365
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07008365. Randomized; no masking; primary purpose treatment. Start 2025-03-10 (actual); primary completion 2026-11-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Role of intraABDOminal Pressure and Point Of Care UltraSound to Guide Decongestive Therapy in Heart Failure
Acronym
ABDOPOCUS-HF
Condition
Acute Heart Failure
Condition
Congestive Heart Failure
Condition
Intraabdominal Hypertension
Condition
Cardio-Renal Syndrome
Intervention (Drug)
Furosemide 20 Milligrams
Lead sponsor
Instituto de Investigación Sanitaria Aragón (class: other)

Record details

Record id
cardio:ct-nct07008365
Content hash
0b7bc92228cf52e4b24a49a5d37fb6fbf8dd5fb3b334cff26d3dd9ebeefbdc8b